Abstract
SK& F 17910-A, (2-chloro-1O-(β-dimethylaminopropionyl)-pheno-thiazine-5-oxide hydrochloride), has antiinflammatory activity qualitatively and quantitatively similar to that produced by hydrocortisone. Oral antiinflammatory activity of SK& F 17910-A was 1ı5 to 03 times that of hydrocortisone in intact animals, using the pleural fluid, rat paw edema, carrageenan abscess and granuloma tests. SK& F 17910-A exhibited some thymolytic activity but did not cause adrenal atrophy or hyperplasia. In adrenolectomized (ADX) animals, SK& F 17910-A had a quantitatively similar antiinflammatory activity, clearly demonstrating that this activity was not the result of adrenal stimulation. Although SK& F 17910-A shares the antiiiiflammatory activity of hydrocortisone, it differs from hydrocortisone in having no effect upon glycogen deposition. But again, like hydrocortisone, SK& F 17910-A was inactive in the ultraviolet (UV) erythema test, a procedure which actively selects the known nonsteroidal antiinflammatory agents. In the water-unloading test in ADX rats, SK& F 17910-A and the glucocorticoids were unique in their ability to repair the defects in the excretion of a water load. Since other nonsteroidal antiinflammatory compounds were inactive in this procedure, it is concluded that SK& F 17910-A is a unique nonsteroidal antiinflammatory agent having some of the properties of the glucocorticoids.
Footnotes
- Received February 5, 1968.
- Accepted May 28, 1968.
- © 1968, by The Williams & Wilkins Company
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|